Impact of GLP-1 Receptor Agonist Use on Total Knee Arthroplasty Outcomes in Metformin-Treated Diabetic Patients With and Without Comorbid Obesity: A Propensity-Matched Analysis - PubMed
2 days ago
- #diabetes and obesity
- #GLP-1 receptor agonists
- #total knee arthroplasty
- GLP-1 receptor agonists (GLP-1RAs) improve outcomes in total knee arthroplasty (TKA) for diabetic patients.
- Study evaluates GLP-1RA impact on TKA outcomes in metformin-treated T2DM patients, stratified by obesity.
- Obese patients on GLP-1RAs showed reduced postoperative anemia, acute kidney injury, and 90-day readmissions.
- Non-obese patients on GLP-1RAs had lower 90-day readmission and ED visit rates but no other notable differences.
- GLP-1RAs reduce resource utilization in TKA patients regardless of obesity, with added benefits in obese patients.
- Findings suggest a synergistic effect between weight loss and glycemic control in obese patients using GLP-1RAs.